相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
CXD101
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
934828-12-3
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1287.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥700.0 |
| 规格: | 5 mg | 产品价格: | ¥1450.0 |
| 规格: | 10 mg | 产品价格: | ¥2200.0 |
| 规格: | 25 mg | 产品价格: | ¥3850.0 |
| 规格: | 50 mg | 产品价格: | ¥5580.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Zabadinostat
CAS No. : 934828-12-3
MCE 国际站:Zabadinostat
产品活性:Zabadinostat (CXD101) 是一种有效的,选择性的,具有口服活性的 I 类 HDAC 抑制剂,对 HDAC1,HDAC2 和 HDAC3 的 IC50 分别为 63 nM,570 nM 和 550 nM。Zabadinostat 对 II 类 HDAC 没有活性,并具有抗肿瘤活性。
研究领域:Cell Cycle/DNA Damage | Epigenetics
作用靶点:HDAC
In Vitro: Zabadinostat has been tested in vitro in colon, lung, non-Hodgkin lymphoma, and myeloma cell lines with IC50s ranged from 0.2 to 15 μM.
In Vivo: Zabadinostat substantially reduces tumor size in murine xenograft lung (A549a) and colon (HT29) models at a dose of 50 mg/kg. Tumor reductions are found to be associated with increased histone acetylation and decreased HDAC enzyme activity.
For Zabadinostat, after oral dosing in murine and canine models, peak plasma concentrations (Cmax) are reached 1 to 2 hours after the dose and terminal half‐lives are 6 hours and 8 hours, respectively. After murine oral [14C]-Zabadinostat at a dose of 1.6 mg/kg (4 μmol/kg), tissue radioactivity peaked 3 to 6 hours after the dose and declined slowly thereafter with Zabadinostat‐related material still present in tissue 21 days after the dose.
相关产品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Epigenetics Compound Library | Histone Modification Research Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Anti-COVID-19 Compound Library | Orally Active Compound Library | Anti-Breast Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Anti-Liver Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Osteogenesis Compound Library | Heterocyclic Compound Library | Highly Selective Inhibitors Library | Trichostatin A | Vorinostat | 4-Phenylbutyric acid | Valproic acid | Sulforaphane | Panobinostat | Entinostat | Romidepsin | Tucidinostat | RGFP966 | Belinostat | Ricolinostat | Tubastatin A | TMP195 | Theophylline | Carbamazepine | Mocetinostat | Santacruzamate A | ITSA-1 | TMP269 | Tasquinimod | Fimepinostat | Tubacin | LMK-235 | Quisinostat | PCI-34051 | FT895
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
















